Physician profile
Gregory M Graves
NPI 1548243033
$92,648.09
in general payments reported to CMS, 2019-2025
32 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,613 · 2020: $8,057 · 2021: $19K · 2022: $8,490 · 2023: $41K · 2024: $12K · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $7,860 · Food and Beverage: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,450.00 |
| Travel and Lodging | $7,859.59 |
| Food and Beverage | $2,404.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $89,024.87 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| E.R. Squibb & Sons, L.L.C. | $720.02 | 2019-2024 | Opdivo, Opdualag |
| Jazz Pharmaceuticals INC. | $523.53 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $478.28 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $421.39 | 2019-2025 | Keytruda |
| Elekta, INC. | $181.51 | 2020 | |
| Lexington Medical, INC. | $163.65 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Zimmer Biomet Holdings, INC. | $162.10 | 2019-2024 | Ribfix Blu Advantage, Advantagerib |
| Seagen INC. | $114.21 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $95.12 | 2021-2022 | |
| Tela Bio, INC. | $83.95 | 2019-2024 | Ovitex 2s |
| Immunocore Limited | $68.08 | 2024 | Kimmtrak |
| Histosonics, INC. | $54.77 | 2024 | |
| Genzyme Corporation | $47.87 | 2021 | |
| Ferring Pharmaceuticals INC. | $46.21 | 2022-2024 | Rebyota |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $44.34 | 2019-2020 | |
| Helsinn Therapeutics (U.S.), INC. | $42.95 | 2019 | |
| Baudax Bio INC. | $42.25 | 2020 | |
| Acell, INC. | $38.75 | 2020 | |
| Atricure, INC. | $37.81 | 2019-2023 | |
| Allergan, INC. | $36.60 | 2019 | |
| Livanova USA, INC. | $34.55 | 2020 | |
| Lsi Solutions INC | $27.78 | 2023 | Cor Knot |
| Baxter Healthcare | $25.40 | 2020 | |
| Angiodynamics, INC. | $22.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.39 | 2022 | |
| Sirtex Medical INC | $17.12 | 2020 | |
| Organogenesis INC. | $16.47 | 2023 | Puraply |
| Orthofix Medical, INC. | $15.61 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.25 | 2021 | |
| Janssen Biotech, INC. | $15.14 | 2020 | |
| Olympus America INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.